##plugins.themes.academic_pro.article.sidebar##
Submitted
Sep 20, 2024
Published
Sep 30, 2024
Download
Statistic
Read Counter : 31
Download : 30
Main Article Content
Abstract
Exoftalmus merupakan manifestasi paling umum terjadi pada Thyroid-associated ophthalmopathy (TAO) atau Grave’s Ophthalmopathy (GO). Dimana GO bisa terjadi pada pasien dengan hipertiroid, hipotiroid ataupun eutiroid. Katarak sendiri merupakan penyebab utama terjadinya gangguan penglihatan di dunia.
Pada laporan kasus, pasien laki-laki usia 60 tahun datang dirujuk dari RS lain dengan keluhan kedua mata kabur dan menonjol. Pada pemeriksaan fisik didapatkan visus okuli dextra 1/60 dan okuli sinistra 1/300, kedua mata proptosis, dan pada pemeriksaan segmen anterior terdapat kekeruhan pada lensa. Tidak didapatkan pembesaran kelenjar tiroid, kadar FT4 normal yakni 1.28 ng/dL. Selanjutnya pada pasien dilakukan operasi katarak secara bertahap dengan tehnik ECCE disertai pemsangan IOL dan kemudian diberi obat tetes mata Xitrol Eyedrop dan Lyteers Eyedrop dilanjutkan dengan control rutin berkala untuk evaluasi.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
1. Aronson JK, Ramachandran M. The Diagnosis of Art: exophthalmos—Gustave Dore´’s ogre. J R Soc Med [Internet]. 2006 Aug;Volume 99. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1533514/
2. Vaughan & Asbury’s General Ophthalmology. 19th ed. Riordan-Eva P, Augsburger JJ, editors. NewYork: McGrawHilleducation; 2018.
3. Şahlı E, Gündüz K. Thyroid-associated ophthalmopathy. Vol. 47, Turk Oftalmoloiji Dergisi. Turkish Ophthalmology Society; 2017. p. 94–105.
4. Boddu N, Jumani M, Wadhwa V, Bajaj G, Faas F. Not all orbitopathy is Graves’: Discussion of cases and review of literature. Front Endocrinol (Lausanne). 2017 Jul 31;8(JUL).
5. Muñoz-Ortiz J, Sierra-Cote MC, Zapata-Bravo E, Valenzuela-Vallejo L, Marin-Noriega MA, Uribe-Reina P, et al. Prevalence of hyperthyroidism, hypothyroidism, and euthyroidism in thyroid eye disease: A systematic review of the literature. Vol. 9, Systematic Reviews. BioMed Central; 2020.
6. Macovei ML, Azis Ű, Gheorghe A, Burcea M. A systematic review of euthyroid Graves’ disease (Review). Exp Ther Med. 2021 Sep 22;22(5).
7. Werner SC, York N. Euthyroid Patients with Early Eye Signs of Graves’ Disease* Their Responses to L-Triiodothyronine and Thyrotropin.
8. Liddle GW, Heyssel RM, Mckenzie JM. Graves’ Disease Without Hyperthyroidism*.
9. Shiels A, Fielding Hejtmancik J. Biology of Inherited Cataracts and Opportunities for Treatment. 2019; Available from: https://doi.org/10.1146/annurev-vision-091517-
10. Hashemi H, Pakzad R, Yekta A, Aghamirsalim M, Pakbin M, Ramin S, et al. Global and regional prevalence of age-related cataract: a comprehensive systematic review and meta-analysis. Vol. 34, Eye (Basingstoke). Springer Nature; 2020. p. 1357–70.
11. Nizami AA, Gurnani B, Gulani AC. Cataract. StatPearls Publishing [Internet]. 2024 Jan; Available from: https://www.ncbi.nlm.nih.gov/books/NBK539699/#article-19005.s3
12. Komoto N, Kozaki A, Yu F, Inoue R, Maeda T, Inoue T, et al. Clinical Feature of Euthyroid Grave’s Ophthalmopathy . Investigate Ophthalmology and Visual Science [Internet]. 2008 May;Volume 49(Issue 13). Available from: https://iovs.arvojournals.org/article.aspx?articleid=2380631
13. Gounder P, Oliphant H, Juniat V, Koenig M, Selva D, Rajak SN. Histopathological features of asymmetric lacrimal gland enlargement in patients with thyroid eye disease. Thyroid Res. 2023 Dec 1;16(1).
14. Bartley GB, Gorman CA. Diagnostic criteria for Graves’ ophthalmopathy. Am J Ophthalmol. 1995;119(6):792–5.
15. Yu CY, Ford RL, Wester ST, Shriver EM. Update on thyroid eye disease: Regional variations in prevalence, diagnosis, and management. Vol. 70, Indian Journal of Ophthalmology. Wolters Kluwer Medknow Publications; 2022. p. 2335–45.
16. Termote K, Decallonne B, Mombaerts I. The influence of prior hyperthyroidism on euthyroid Graves’ ophthalmopathy. J Ophthalmol. 2014;2014.
17. Irvine ARJr. Exophthalmos From the Standpoint of the Ophthalmologist. National Center for Biotechnology Information [Internet]. 1954 Feb; Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1531777/
18. Anidha Y, Ayu WC, Sari NMW, Nadhiroh SR. Faktor Resiko dan Manifestasi Klinis Pada Hipertiroid: Tinjauan sistematis. Amerta Nutrition [Internet]. 2023 Dec 31;Volume 7. Available from: https://e-journal.unair.ac.id/AMNT/article/view/49141/27682
19. Indonesian Clinical Practice Guidelines for Hyperthyroidism. 2012; Available from: www.asean-endocrinejournal.org
20. Marcocci C, Marinò M. Treatment of mild, moderate-to-severe and very severe Graves’ orbitopathy. Vol. 26, Best Practice and Research: Clinical Endocrinology and Metabolism. 2012. p. 325–37.
21. Rusmini H, Ma’rifah S. Gambaran Penggunaan Kortikosteroid Sistemik Jangka Panjang Terhadap Kejadian Katarak di Poli Mata Rumah Sakit Pertamina Bintang Amin bandar Lampung. Jurnal Ilmu Kedokteran Dan Kesehatan [Internet]. 2017 Apr;Volume 4. Available from: https://ejurnalmalahayati.ac.id/index.php/kesehatan/article/viewFile/776/718
2. Vaughan & Asbury’s General Ophthalmology. 19th ed. Riordan-Eva P, Augsburger JJ, editors. NewYork: McGrawHilleducation; 2018.
3. Şahlı E, Gündüz K. Thyroid-associated ophthalmopathy. Vol. 47, Turk Oftalmoloiji Dergisi. Turkish Ophthalmology Society; 2017. p. 94–105.
4. Boddu N, Jumani M, Wadhwa V, Bajaj G, Faas F. Not all orbitopathy is Graves’: Discussion of cases and review of literature. Front Endocrinol (Lausanne). 2017 Jul 31;8(JUL).
5. Muñoz-Ortiz J, Sierra-Cote MC, Zapata-Bravo E, Valenzuela-Vallejo L, Marin-Noriega MA, Uribe-Reina P, et al. Prevalence of hyperthyroidism, hypothyroidism, and euthyroidism in thyroid eye disease: A systematic review of the literature. Vol. 9, Systematic Reviews. BioMed Central; 2020.
6. Macovei ML, Azis Ű, Gheorghe A, Burcea M. A systematic review of euthyroid Graves’ disease (Review). Exp Ther Med. 2021 Sep 22;22(5).
7. Werner SC, York N. Euthyroid Patients with Early Eye Signs of Graves’ Disease* Their Responses to L-Triiodothyronine and Thyrotropin.
8. Liddle GW, Heyssel RM, Mckenzie JM. Graves’ Disease Without Hyperthyroidism*.
9. Shiels A, Fielding Hejtmancik J. Biology of Inherited Cataracts and Opportunities for Treatment. 2019; Available from: https://doi.org/10.1146/annurev-vision-091517-
10. Hashemi H, Pakzad R, Yekta A, Aghamirsalim M, Pakbin M, Ramin S, et al. Global and regional prevalence of age-related cataract: a comprehensive systematic review and meta-analysis. Vol. 34, Eye (Basingstoke). Springer Nature; 2020. p. 1357–70.
11. Nizami AA, Gurnani B, Gulani AC. Cataract. StatPearls Publishing [Internet]. 2024 Jan; Available from: https://www.ncbi.nlm.nih.gov/books/NBK539699/#article-19005.s3
12. Komoto N, Kozaki A, Yu F, Inoue R, Maeda T, Inoue T, et al. Clinical Feature of Euthyroid Grave’s Ophthalmopathy . Investigate Ophthalmology and Visual Science [Internet]. 2008 May;Volume 49(Issue 13). Available from: https://iovs.arvojournals.org/article.aspx?articleid=2380631
13. Gounder P, Oliphant H, Juniat V, Koenig M, Selva D, Rajak SN. Histopathological features of asymmetric lacrimal gland enlargement in patients with thyroid eye disease. Thyroid Res. 2023 Dec 1;16(1).
14. Bartley GB, Gorman CA. Diagnostic criteria for Graves’ ophthalmopathy. Am J Ophthalmol. 1995;119(6):792–5.
15. Yu CY, Ford RL, Wester ST, Shriver EM. Update on thyroid eye disease: Regional variations in prevalence, diagnosis, and management. Vol. 70, Indian Journal of Ophthalmology. Wolters Kluwer Medknow Publications; 2022. p. 2335–45.
16. Termote K, Decallonne B, Mombaerts I. The influence of prior hyperthyroidism on euthyroid Graves’ ophthalmopathy. J Ophthalmol. 2014;2014.
17. Irvine ARJr. Exophthalmos From the Standpoint of the Ophthalmologist. National Center for Biotechnology Information [Internet]. 1954 Feb; Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1531777/
18. Anidha Y, Ayu WC, Sari NMW, Nadhiroh SR. Faktor Resiko dan Manifestasi Klinis Pada Hipertiroid: Tinjauan sistematis. Amerta Nutrition [Internet]. 2023 Dec 31;Volume 7. Available from: https://e-journal.unair.ac.id/AMNT/article/view/49141/27682
19. Indonesian Clinical Practice Guidelines for Hyperthyroidism. 2012; Available from: www.asean-endocrinejournal.org
20. Marcocci C, Marinò M. Treatment of mild, moderate-to-severe and very severe Graves’ orbitopathy. Vol. 26, Best Practice and Research: Clinical Endocrinology and Metabolism. 2012. p. 325–37.
21. Rusmini H, Ma’rifah S. Gambaran Penggunaan Kortikosteroid Sistemik Jangka Panjang Terhadap Kejadian Katarak di Poli Mata Rumah Sakit Pertamina Bintang Amin bandar Lampung. Jurnal Ilmu Kedokteran Dan Kesehatan [Internet]. 2017 Apr;Volume 4. Available from: https://ejurnalmalahayati.ac.id/index.php/kesehatan/article/viewFile/776/718